Clinical trial
Phase 1 Safety Study of Two Experimental HIV Vaccines
NCT00479999 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00479999 |
|---|---|
| Title | Phase 1 Safety Study of Two Experimental HIV Vaccines |
| Official title | VRC 012: A Phase I Clinical Trial of the Safety and Immunogenicity of an HIV-1 Adenoviral Vector Serotype 35 Vaccine: Dose Escalation as a Single Agent and Prime-Boost Schedules With an HIV-1 Adenoviral Vector Serotype 5 Vaccine in Uninfected Adults |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | AIDS Vaccines, HIV Infections, HIV-1 |
| Intervention type | Drug |
| Interventions | VRC-HIVADV027-00-VP, VRC-HIVADV038-00-VP |
| Enrollment | 35 |
| Start date | May 24, 2007 |
| Primary completion | May 5, 2014 |
| Completion | May 5, 2014 |
| First posted | May 30, 2007 |
| Last update posted | Dec 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: